Barrow Hanley Mewhinney & Strauss LLC reduced its position in The Clorox Company (NYSE:CLX – Free Report) by 11.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 93,827 shares of the company’s stock after selling 12,550 shares during the period. Barrow Hanley Mewhinney & Strauss LLC owned about 0.08% of Clorox worth $7,601,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of CLX. NewEdge Advisors LLC grew its position in Clorox by 11.8% in the second quarter. NewEdge Advisors LLC now owns 75,135 shares of the company’s stock worth $7,171,000 after acquiring an additional 7,956 shares in the last quarter. Public Employees Retirement System of Ohio bought a new stake in Clorox during the second quarter worth approximately $3,277,000. Corient Private Wealth LP acquired a new position in Clorox during the second quarter valued at approximately $6,621,000. Equity Investment Corp grew its holdings in Clorox by 34.8% during the third quarter. Equity Investment Corp now owns 1,578,983 shares of the company’s stock valued at $127,913,000 after purchasing an additional 407,569 shares during the last quarter. Finally, Allen Mooney & Barnes Investment Advisors LLC raised its position in shares of Clorox by 3,309.3% in the third quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 186,316 shares of the company’s stock valued at $15,093,000 after purchasing an additional 180,851 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Clorox news, Director Pierre Breber purchased 4,000 shares of the firm’s stock in a transaction on Wednesday, November 4th. The shares were purchased at an average cost of $100.06 per share, with a total value of $400,240.00. Following the completion of the purchase, the director owned 22,000 shares of the company’s stock, valued at $2,201,320. The trade was a 22.22% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.51% of the stock is owned by insiders.
Clorox Stock Performance
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings data on Monday, November 2nd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.07 by $0.48. The business had revenue of $1.91 billion for the quarter, compared to analyst estimates of $1.88 billion. Clorox had a net margin of 9.41% and a return on equity of 608.30%. The company’s revenue for the quarter was up 33.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.85 earnings per share. On average, research analysts anticipate that The Clorox Company will post 5.74 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, February 12th. Stockholders of record on Wednesday, January 27th will be issued a $1.25 dividend. The ex-dividend date of this dividend is Wednesday, January 27th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 4.8%. Clorox’s dividend payout ratio is presently 89.93%.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the stock. UBS Group set a $88.00 price target on shares of Clorox in a report on Tuesday, November 3rd. Citigroup dropped their price objective on shares of Clorox from $97.00 to $90.00 and set a “neutral” rating on the stock in a report on Wednesday, October 14th. Barclays cut their price objective on shares of Clorox from $84.00 to $80.00 and set an “underweight” rating for the company in a research report on Friday, October 16th. JPMorgan Chase & Co. upped their price objective on Clorox from $83.00 to $86.00 and gave the company an “underweight” rating in a research note on Tuesday, November 3rd. Finally, Evercore raised Clorox from an “underperform” rating to a “hold” rating and set a $99.00 price objective on the stock in a research note on Monday, November 2nd. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Reduce” and an average price target of $93.79.
Read Our Latest Research Report on Clorox
About Clorox
The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care. Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt’s Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.
Further Reading
- Five stocks we like better than Clorox
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
